News

Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3
AV Access Study to be Presented at the Vascular Annual Meeting (VAM25)DURHAM, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company ...
NBC Los Angeles on MSN7d
California man receives world's first in-human bladder transplant
A California cancer survivor was the recipient of the world's first in-human bladder transplant this month thanks to a pair ...
Vadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of Nephrology
Akebia continues to publish important, clinically relevant data to further physicians’ understanding of Vafseo® ...
STAT1mon
FDA OKs trial of pig livers as dialysis-like treatment for liver failure
The first-of-its-kind clinical trial has been cleared by the Food and Drug Administration, according to pig producer eGenesis, which announced the step Tuesday with its partner OrganOx.